1887

Abstract

Summary

Ashdown’s selective-differential agar medium, with or without preenrichment in selective broth, was evaluated for the isolation of from 1972 clinical specimens obtained from 643 subjects in Northeast Thailand; 226 patients proved to have melioidosis. The use of Ashdown’s medium significantly increased the frequency of recovery of from sites or specimens with an extensive normal flora (throat, rectum, wounds and sputum) as compared to the recovery on blood and MacConkey agars (p<0.01). The isolation frequency from throat, rectal and wound swabs was further increased by the use of the broth pre-enrichment. The colonial morphology of on Ashdown’s medium was sufficiently characteristic to allow presumptive identification. With the use of these selective media it was possible to culture from throat swabs taken from 87% of the patients from whom the organism could also be isolated from corresponding tracheal aspirates or sputum specimens. was isolated from rectal swabs taken from 51 patients, the first time that faecal excretion of the organism has been demonstrated in man. The diagnosis of melioidosis would not have been confirmed bacteriologically in eight patients (3.5%) without the use of the selective media. It is suggested that, in areas endemic for melioidosis, all sputum specimens should be cultured on selective media, such as Ashdown’s. For the investigation of clinically suspected cases of melioidosis, and for follow-up during treatment of the disease, the use of broth pre-enrichment is recommended for specimens obtained from sites with an extensive normal flora.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-33-2-121
1990-10-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/33/2/medmicro-33-2-121.html?itemId=/content/journal/jmm/10.1099/00222615-33-2-121&mimeType=html&fmt=ahah

References

  1. Chaowagul W, White NJ, Dance DAB et al. Melioidosis: a major cause of community-acquired septicemia in Northeastern Thailand. J Infect Dis 1989; 159:890–899
    [Google Scholar]
  2. Leelarasamee A, Bovomkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11:413–425
    [Google Scholar]
  3. Sanford JP. Pseudomonas species (including melioidosis and glanders). In: Mandell GL, Douglas RG, Bennett JE. (eds) Principles and Practice of Infectious Diseases, 2nd edn.. New York: John Wiley & Sons; 19851250–1254
    [Google Scholar]
  4. Ashdown LR. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979; 11:293–297
    [Google Scholar]
  5. Farkas-Himsley H. Selection and rapid identification of Pseudomonas pseudomallei from other gram-negative bacteria. Am J Clin Pathol 1968; 49:850–856
    [Google Scholar]
  6. Galimand M, Dodin A. Le point sur la melioidose dans le monde. Bull Soc Pathol Exot Filiales 1982; 75:375–383
    [Google Scholar]
  7. Khanthawa B, Tharavichitkul P. Selective medium for Pseudomonas pseudomallei. In: Punyagupta S, Sirisan-Thana T, Stapatayavong B. (eds) Melioidosis Bangkok: Bangkok Medical Publisher; 1989154–157
    [Google Scholar]
  8. Dance DAB, Wuthiekanun V, Naigowit P, White NJ. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and the API 20NE. J Clin Pathol 1989; 42:645–648
    [Google Scholar]
  9. Siegel S. The case of two related samples. In: Nonparametric statistics for the behavioural sciences New York: McGraw-Hill; 195661–94
    [Google Scholar]
  10. White NJ, Dance DAB. Clinical and laboratory studies of malaria and melioidosis. Trans R Soc Trop Med Hyg 1988; 82:15–20
    [Google Scholar]
  11. Silpapojakul K, Ratanachai S, Mutirakul P, Silpapojakul K, Kalnaowakul S. Melioidosis in Southern Thailand: III. Pharyngocervical melioidosis. In: Punyagupta S, Sirisanthana T, Stapatayavong B. (eds) Melioidosis Bangkok: Bangkok Medical Publisher; 198980–84
    [Google Scholar]
  12. Dance DAB, Wuthiekanun V, Chaowagul W, White NJ. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989; 24:295–309
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-33-2-121
Loading
/content/journal/jmm/10.1099/00222615-33-2-121
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error